Relationship between a Weighted Multi-Gene Algorithm and Blood Pressure Controlin Hypertension
Autor: | Danielle M. Walla, Eric M. Snyder, Monica K. Akre, Thomas P. Olson, Pamela Phelps, Emma K. Bulock, Eli F. Kelley, Ryan Sprissler, Jerad J. Simmons, Audrie Ayres, Jennifer K Ross |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Blood pressure control
hypertension Medication history Complex disease lcsh:Medicine 030204 cardiovascular system & hematology Article 03 medical and health sciences pharmacotherapy 0302 clinical medicine Pharmacotherapy Medicine genetics cardiovascular diseases Family history pharmacogenetics treatment business.industry lcsh:R blood pressure General Medicine Multi gene Blood pressure business Algorithm 030217 neurology & neurosurgery Pharmacogenetics |
Zdroj: | Journal of Clinical Medicine Volume 8 Issue 3 Journal of Clinical Medicine, Vol 8, Iss 3, p 289 (2019) |
ISSN: | 2077-0383 |
DOI: | 10.3390/jcm8030289 |
Popis: | Hypertension (HTN) is a complex disease with interactions among multiple organ systems, including the heart, vasculature, and kidney with a strong heritable component. Despite the multifactorial nature of HTN, no clinical guidelines utilize a multi-gene approach to guide blood pressure (BP) therapy. Non-smokers with a family history of HTN were included in the analysis (n = 384 age = 61.0 ± 0.9, 11% non-white). A total of 17 functional genotypes were weighted according to the previous effect size in the literature and entered into an algorithm. Pharmacotherapy was ranked from 1&ndash 4 as most to least likely to respond based on the algorithmic assessment of individual patient&rsquo s genotypes. Three-years of data were assessed at six-month intervals for BP and medication history. There was no difference in BP at diagnosis between groups matching the top drug recommendation using the multi-gene weighted algorithm (n = 92) vs. those who did not match (n = 292). However, from diagnosis to nadir, patients who matched the primary recommendation had a significantly greater drop in BP when compared to patients who did not. Further, the difference between diagnosis to current 1-year average BP was lower in the group that matched the top recommendation. These data suggest an association between a weighted multi-gene algorithm on the BP response to pharmacotherapy. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |